Literature DB >> 391150

Antimicrobial susceptibility of clinical isolates of Serratia marcescens.

J S Alvarez, B Regueiro, M J Garrido.   

Abstract

The in vitro susceptibilities of 242 isolates of Serratia marcescens to 17 antibacterial drugs have been determined. Oxolinic acid, nalidixic acid, cefoxitin, and amikacin were the most active drugs. Ampicillin, kanamycin, and cephalothin were among the least active. A 4-year study showed that resistance of S. marcescens to dibekacin, tobramycin, sisomycin, and gentamicin has increased at least one order of magnitude in that period, whereas resistance to amikacin showed but a twofold increase.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 391150      PMCID： PMC352893          DOI： 10.1128/AAC.16.4.523

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  4 in total

Review 1.  Cefoxitin, a semi-synthetic cephamycin: a microbiological overview.

Authors:  J Birnbaum; E O Stapley; A K Miller; H Wallick; D Hendlin; H B Woodruff
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

2.  Activity of eight aminoglycosides against isolates of Serratia marcescens from four hospitals.

Authors:  L Verbist; J Vandepitte; J Vandeven
Journal:  J Antimicrob Chemother       Date:  1978-01       Impact factor: 5.790

3.  Antibiotic resistance patterns of clinical isolates of Serratia marcescens.

Authors:  R C Cooksey; E R Bannister; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

4.  Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens.

Authors:  P Greenup; D J Blazevic
Journal:  Appl Microbiol       Date:  1971-09
  4 in total
  1 in total

1.  Outbreak of nosocomial urinary tract infections caused by Serratia marcescens.

Authors:  T Okuda; N Endo; Y Osada; H Zen-Yoji
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.